_id
69105b30ccc777a4e85d57de
Ticker
DIUXF
Name
Diaceutics PLC
Exchange
PINK
Address
Building Two, Belfast, United Kingdom, BT9 6GW
Country
USA
Sector
Healthcare
Industry
Health Information Services
Currency
USD
Website
https://www.diaceutics.com
Description
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers professional services, such as market landscape, implementation, and consulting services. It operates in North America, the United Kingdom, Europe, Asia, and internationally. The company was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Last Close
1.3672
Volume
17746
Current Price
1.3672
Change
0
Last Updated
2026-01-02T12:37:15.000Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
115698752
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
14564000
Cost Of Revenue
2477000
Gross Profit
12087000
Operating Expenses
15266000
Operating Income
-3179000
Interest Expense
-
Pretax Income
-3013000
Net Income
-2401000
Eps
-0.028400191654571152
Dividends Per Share
-
Shares Outstanding
84624602
Income Tax Expense
612000
EBITDA
-1341000
Operating Margin
-21.827794561933533
Total Other Income Expense Net
166000
Cash
10384000
Short Term Investments
-
Receivables
11695000
Inventories
-
Total Current Assets
24464000
Property Plant Equipment
1711000
Total Assets
44423000
Payables
1073000
Short Term Debt
229000
Long Term Debt
-
Total Liabilities
7182000
Equity
37241000
Bs_currency_symbol
GBP
Depreciation
2701000
Change In Working Capital
3863000
Cash From Operations
605000
Capital Expenditures
55000
Cash From Investing
-2627000
Cash From Financing
-141000
Net Change In Cash
10384000
Cf_currency_symbol
-
PE
-
PB
3.103713353497489
ROE
-6.4471952955076395
ROA
-5.404857843909686
FCF
550000
Fcf Percent
0.0377643504531722
Piotroski FScore
2
Health Score
32
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
5.8
Garp Investing Score
4
Growth Investing Score
3
Momentum Investing Score
2.5
Net Net Investing Score
4
Quality Investing Score
4.5
Value Investing Score
4
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
14564000
Quarters > 0 > income Statement > cost Of Revenue
2477000
Quarters > 0 > income Statement > gross Profit
12087000
Quarters > 0 > income Statement > operating Expenses
15266000
Quarters > 0 > income Statement > operating Income
-3179000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-3013000
Quarters > 0 > income Statement > net Income
-2401000
Quarters > 0 > income Statement > eps
-0.028400191654571152
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
84541683
Quarters > 0 > income Statement > income Tax Expense
612000
Quarters > 0 > income Statement > EBITDA
-1341000
Quarters > 0 > income Statement > operating Margin
-21.827794561933533
Quarters > 0 > income Statement > total Other Income Expense Net
166000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
10384000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
11695000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
24464000
Quarters > 0 > balance Sheet > property Plant Equipment
1711000
Quarters > 0 > balance Sheet > total Assets
44423000
Quarters > 0 > balance Sheet > payables
1073000
Quarters > 0 > balance Sheet > short Term Debt
229000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
7182000
Quarters > 0 > balance Sheet > equity
37241000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-2401000
Quarters > 0 > cash Flow > depreciation
2701000
Quarters > 0 > cash Flow > change In Working Capital
3863000
Quarters > 0 > cash Flow > cash From Operations
605000
Quarters > 0 > cash Flow > capital Expenditures
55000
Quarters > 0 > cash Flow > cash From Investing
-2627000
Quarters > 0 > cash Flow > cash From Financing
-141000
Quarters > 0 > cash Flow > net Change In Cash
10384000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.028400191654571152
Quarters > 0 > ratios > PB
3.103713353497489
Quarters > 0 > ratios > ROE
-6.4471952955076395
Quarters > 0 > ratios > ROA
-5.404857843909686
Quarters > 0 > ratios > FCF
550000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.0377643504531722
Quarters > 0 > health Score
32
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
19838000
Quarters > 1 > income Statement > cost Of Revenue
2299000
Quarters > 1 > income Statement > gross Profit
17539000
Quarters > 1 > income Statement > operating Expenses
16409000
Quarters > 1 > income Statement > operating Income
1130000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
1356000
Quarters > 1 > income Statement > net Income
881000
Quarters > 1 > income Statement > eps
0.010431491234599076
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
84455806
Quarters > 1 > income Statement > income Tax Expense
475000
Quarters > 1 > income Statement > EBITDA
2667000
Quarters > 1 > income Statement > operating Margin
5.69613872366166
Quarters > 1 > income Statement > total Other Income Expense Net
226000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
12744000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
14961000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
29529000
Quarters > 1 > balance Sheet > property Plant Equipment
1678000
Quarters > 1 > balance Sheet > total Assets
48620000
Quarters > 1 > balance Sheet > payables
1217000
Quarters > 1 > balance Sheet > short Term Debt
153000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
8763000
Quarters > 1 > balance Sheet > equity
39857000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
881000
Quarters > 1 > cash Flow > depreciation
2352000
Quarters > 1 > cash Flow > change In Working Capital
-6292000
Quarters > 1 > cash Flow > cash From Operations
-501000
Quarters > 1 > cash Flow > capital Expenditures
39000
Quarters > 1 > cash Flow > cash From Investing
-2934000
Quarters > 1 > cash Flow > cash From Financing
-101000
Quarters > 1 > cash Flow > net Change In Cash
-16748999
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.010431491234599076
Quarters > 1 > ratios > PB
2.897056425802243
Quarters > 1 > ratios > ROE
2.2104021878214617
Quarters > 1 > ratios > ROA
1.8120115178938707
Quarters > 1 > ratios > FCF
-540000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.027220485936082266
Quarters > 1 > health Score
53
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
12320000
Quarters > 2 > income Statement > cost Of Revenue
3707000
Quarters > 2 > income Statement > gross Profit
8613000
Quarters > 2 > income Statement > operating Expenses
12206000
Quarters > 2 > income Statement > operating Income
-3593000
Quarters > 2 > income Statement > interest Expense
28000
Quarters > 2 > income Statement > pretax Income
-3264000
Quarters > 2 > income Statement > net Income
-2584000
Quarters > 2 > income Statement > eps
-0.030597534804932665
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
84451248
Quarters > 2 > income Statement > income Tax Expense
-680000
Quarters > 2 > income Statement > EBITDA
-961000
Quarters > 2 > income Statement > operating Margin
-29.16396103896104
Quarters > 2 > income Statement > total Other Income Expense Net
329000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
16749000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
9684000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
27229000
Quarters > 2 > balance Sheet > property Plant Equipment
1803000
Quarters > 2 > balance Sheet > total Assets
45426000
Quarters > 2 > balance Sheet > payables
610000
Quarters > 2 > balance Sheet > short Term Debt
150000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
6686000
Quarters > 2 > balance Sheet > equity
38740000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-2584000
Quarters > 2 > cash Flow > depreciation
2275000
Quarters > 2 > cash Flow > change In Working Capital
2842000
Quarters > 2 > cash Flow > cash From Operations
1501000
Quarters > 2 > cash Flow > capital Expenditures
61000
Quarters > 2 > cash Flow > cash From Investing
-1446000
Quarters > 2 > cash Flow > cash From Financing
37000
Quarters > 2 > cash Flow > net Change In Cash
81999
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.030597534804932665
Quarters > 2 > ratios > PB
2.980427110624677
Quarters > 2 > ratios > ROE
-6.670108415074857
Quarters > 2 > ratios > ROA
-5.688372297803021
Quarters > 2 > ratios > FCF
1440000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.11688311688311688
Quarters > 2 > health Score
45
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
6160000
Quarters > 3 > income Statement > cost Of Revenue
794500
Quarters > 3 > income Statement > gross Profit
5365500
Quarters > 3 > income Statement > operating Expenses
7158000
Quarters > 3 > income Statement > operating Income
-1792500
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-1632000
Quarters > 3 > income Statement > net Income
-1292000
Quarters > 3 > income Statement > eps
-0.015298767402466332
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
84451248
Quarters > 3 > income Statement > income Tax Expense
340000
Quarters > 3 > income Statement > EBITDA
-1057500
Quarters > 3 > income Statement > operating Margin
-29.09902597402597
Quarters > 3 > income Statement > total Other Income Expense Net
160500
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
16748999
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
8738000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
27229000
Quarters > 3 > balance Sheet > property Plant Equipment
1803000
Quarters > 3 > balance Sheet > total Assets
45426000
Quarters > 3 > balance Sheet > payables
610000
Quarters > 3 > balance Sheet > short Term Debt
150000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
6686000
Quarters > 3 > balance Sheet > equity
38740000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-1292000
Quarters > 3 > cash Flow > depreciation
1137500
Quarters > 3 > cash Flow > change In Working Capital
808000
Quarters > 3 > cash Flow > cash From Operations
576000
Quarters > 3 > cash Flow > capital Expenditures
30500
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
18500
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.015298767402466332
Quarters > 3 > ratios > PB
2.980427110624677
Quarters > 3 > ratios > ROE
-3.3350542075374285
Quarters > 3 > ratios > ROA
-2.8441861489015103
Quarters > 3 > ratios > FCF
545500
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.0885551948051948
Quarters > 3 > health Score
43
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
32158000
Annuals > 0 > income Statement > cost Of Revenue
3888000
Annuals > 0 > income Statement > gross Profit
28270000
Annuals > 0 > income Statement > operating Expenses
30725000
Annuals > 0 > income Statement > operating Income
-2455000
Annuals > 0 > income Statement > interest Expense
54000
Annuals > 0 > income Statement > pretax Income
-1908000
Annuals > 0 > income Statement > net Income
-1703000
Annuals > 0 > income Statement > eps
-0.020164936391584926
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
84453527
Annuals > 0 > income Statement > income Tax Expense
-205000
Annuals > 0 > income Statement > EBITDA
2773000
Annuals > 0 > income Statement > operating Margin
-7.634181230176005
Annuals > 0 > income Statement > total Other Income Expense Net
547000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
12744000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
14961000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
29529000
Annuals > 0 > balance Sheet > property Plant Equipment
1678000
Annuals > 0 > balance Sheet > total Assets
48620000
Annuals > 0 > balance Sheet > payables
1217000
Annuals > 0 > balance Sheet > short Term Debt
153000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
8763000
Annuals > 0 > balance Sheet > equity
39857000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-1908000
Annuals > 0 > cash Flow > depreciation
4627000
Annuals > 0 > cash Flow > change In Working Capital
-1302000
Annuals > 0 > cash Flow > cash From Operations
651000
Annuals > 0 > cash Flow > capital Expenditures
4632000
Annuals > 0 > cash Flow > cash From Investing
-4031000
Annuals > 0 > cash Flow > cash From Financing
-64000
Annuals > 0 > cash Flow > net Change In Cash
-3923000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.020164936391584926
Annuals > 0 > ratios > PB
2.896978250104122
Annuals > 0 > ratios > ROE
-4.272775171237173
Annuals > 0 > ratios > ROA
-3.5026737967914436
Annuals > 0 > ratios > FCF
-3981000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-0.12379501212761988
Annuals > 0 > health Score
36
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
23699000
Annuals > 1 > income Statement > cost Of Revenue
3993000
Annuals > 1 > income Statement > gross Profit
19706000
Annuals > 1 > income Statement > operating Expenses
22724000
Annuals > 1 > income Statement > operating Income
-3018000
Annuals > 1 > income Statement > interest Expense
66000
Annuals > 1 > income Statement > pretax Income
-2438000
Annuals > 1 > income Statement > net Income
-1746000
Annuals > 1 > income Statement > eps
-0.020729739300732703
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
84226819
Annuals > 1 > income Statement > income Tax Expense
-692000
Annuals > 1 > income Statement > EBITDA
2401000
Annuals > 1 > income Statement > operating Margin
-12.734714544917509
Annuals > 1 > income Statement > total Other Income Expense Net
580000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
16667000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
10126000
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
28040000
Annuals > 1 > balance Sheet > property Plant Equipment
1899000
Annuals > 1 > balance Sheet > total Assets
46344000
Annuals > 1 > balance Sheet > payables
1065000
Annuals > 1 > balance Sheet > short Term Debt
146000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
5558000
Annuals > 1 > balance Sheet > equity
40786000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-1746000
Annuals > 1 > cash Flow > depreciation
4773000
Annuals > 1 > cash Flow > change In Working Capital
-1540000
Annuals > 1 > cash Flow > cash From Operations
1311000
Annuals > 1 > cash Flow > capital Expenditures
4855000
Annuals > 1 > cash Flow > cash From Investing
-4209000
Annuals > 1 > cash Flow > cash From Financing
-239000
Annuals > 1 > cash Flow > net Change In Cash
-3174000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.020729739300732703
Annuals > 1 > ratios > PB
2.8233930009513064
Annuals > 1 > ratios > ROE
-4.280880694355906
Annuals > 1 > ratios > ROA
-3.767477990678405
Annuals > 1 > ratios > FCF
-3544000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-0.14954217477530699
Annuals > 1 > health Score
36
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
19504000
Annuals > 2 > income Statement > cost Of Revenue
5467000
Annuals > 2 > income Statement > gross Profit
14037000
Annuals > 2 > income Statement > operating Expenses
13706000
Annuals > 2 > income Statement > operating Income
331000
Annuals > 2 > income Statement > interest Expense
122000
Annuals > 2 > income Statement > pretax Income
478000
Annuals > 2 > income Statement > net Income
724000
Annuals > 2 > income Statement > eps
0.008409850485751918
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
86089521
Annuals > 2 > income Statement > income Tax Expense
-246000
Annuals > 2 > income Statement > EBITDA
3608000
Annuals > 2 > income Statement > operating Margin
1.6970877768662838
Annuals > 2 > income Statement > total Other Income Expense Net
-97000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
19841000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
10427000
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
30896000
Annuals > 2 > balance Sheet > property Plant Equipment
2092000
Annuals > 2 > balance Sheet > total Assets
48256000
Annuals > 2 > balance Sheet > payables
759000
Annuals > 2 > balance Sheet > short Term Debt
124000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
5742000
Annuals > 2 > balance Sheet > equity
42514000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
724000
Annuals > 2 > cash Flow > depreciation
3008000
Annuals > 2 > cash Flow > change In Working Capital
-328000
Annuals > 2 > cash Flow > cash From Operations
5148000
Annuals > 2 > cash Flow > capital Expenditures
4870000
Annuals > 2 > cash Flow > cash From Investing
-4870000
Annuals > 2 > cash Flow > cash From Financing
-132000
Annuals > 2 > cash Flow > net Change In Cash
166000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
0.008409850485751918
Annuals > 2 > ratios > PB
2.768537260930517
Annuals > 2 > ratios > ROE
1.7029684339276474
Annuals > 2 > ratios > ROA
1.5003315649867373
Annuals > 2 > ratios > FCF
278000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.014253486464315013
Annuals > 2 > health Score
53
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
13943000
Annuals > 3 > income Statement > cost Of Revenue
3377000
Annuals > 3 > income Statement > gross Profit
10566000
Annuals > 3 > income Statement > operating Expenses
10253000
Annuals > 3 > income Statement > operating Income
313000
Annuals > 3 > income Statement > interest Expense
88000
Annuals > 3 > income Statement > pretax Income
293000
Annuals > 3 > income Statement > net Income
561000
Annuals > 3 > income Statement > eps
0.006604494552793015
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
84942155
Annuals > 3 > income Statement > income Tax Expense
-268000
Annuals > 3 > income Statement > EBITDA
2112000
Annuals > 3 > income Statement > operating Margin
2.244854048626551
Annuals > 3 > income Statement > total Other Income Expense Net
-88000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
19675000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
7002000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
30062000
Annuals > 3 > balance Sheet > property Plant Equipment
2129000
Annuals > 3 > balance Sheet > total Assets
45013000
Annuals > 3 > balance Sheet > payables
513000
Annuals > 3 > balance Sheet > short Term Debt
276000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
4364000
Annuals > 3 > balance Sheet > equity
40649000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
561000
Annuals > 3 > cash Flow > depreciation
1799000
Annuals > 3 > cash Flow > change In Working Capital
-1658000
Annuals > 3 > cash Flow > cash From Operations
570000
Annuals > 3 > cash Flow > capital Expenditures
5601000
Annuals > 3 > cash Flow > cash From Investing
-5601000
Annuals > 3 > cash Flow > cash From Financing
-270000
Annuals > 3 > cash Flow > net Change In Cash
-5580000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.006604494552793015
Annuals > 3 > ratios > PB
2.8569685432851974
Annuals > 3 > ratios > ROE
1.3801077517282097
Annuals > 3 > ratios > ROA
1.2463066225312687
Annuals > 3 > ratios > FCF
-5031000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
-0.3608262210428172
Annuals > 3 > health Score
54
Valuation > metrics > PE
-0.028400191654571152
Valuation > metrics > PB
3.103713353497489
Valuation > final Score
48.96286646502511
Valuation > verdict
3.5% Overvalued
Profitability > metrics > ROE
-6.4471952955076395
Profitability > metrics > ROA
-9.814421190320472
Profitability > metrics > Net Margin
-0.16485855534193902
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.19285196423296905
Risk > metrics > Interest Coverage
-1.9013157894736843
Risk > final Score
52
Risk > verdict
High
Liquidity > metrics > Current Ratio
18.789554531490015
Liquidity > metrics > Quick Ratio
18.789554531490015
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
20
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
63
Prev Risks > 1
-453
Prev Risks > 2
48
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:42:53.232Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-11
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-03-31
Earnings History > 1 > report Date
2021-06-30
Earnings History > 1 > date
2021-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
GBP
Earnings History > 1 > eps Actual
-0.0028
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.0028
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-12-31
Earnings History > 2 > report Date
2021-03-31
Earnings History > 2 > date
2020-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
GBP
Earnings History > 2 > eps Actual
-0.0028
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.0028
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-09-30
Earnings History > 3 > report Date
2020-12-31
Earnings History > 3 > date
2020-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
-0.0066
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.0066
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-06-30
Earnings History > 4 > report Date
2020-09-30
Earnings History > 4 > date
2020-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
-0.0062
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.0062
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-03-31
Earnings History > 5 > report Date
2020-06-30
Earnings History > 5 > date
2020-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
0.0094
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0.0094
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-12-31
Earnings History > 6 > report Date
2020-03-31
Earnings History > 6 > date
2019-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
0.0094
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0.0094
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-09-30
Earnings History > 7 > report Date
2019-12-31
Earnings History > 7 > date
2019-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
0.0202
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0.0202
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-06-30
Earnings History > 8 > report Date
2019-09-30
Earnings History > 8 > date
2019-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
0.0188
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0.0188
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-06-30
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
-0.0188
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.0188
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-12-31
Earnings History > 10 > report Date
2019-03-31
Earnings History > 10 > date
2018-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
-0.0193
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.0193
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-12-31
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
0.0225
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.0225
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-30
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
0.023
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0.023
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-06-30
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
-0.014
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.014
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-12-31
Earnings History > 14 > report Date
2018-03-31
Earnings History > 14 > date
2017-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
-0.0149
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.0149
Earnings History > 14 > surprise Percent
-
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers professional services, such as market landscape, implementation, and consulting services. It operates in North America, the United Kingdom, Europe, Asia, and internationally. The company was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Diaceutics PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2021-03-31
EPS Actual
-0.0028
EPS Estimate
0
EPS Difference
-0.0028
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.